1160653-94-0 Usage
General Description
3-Bromo-2-fluoro-6-methoxybenzaldehyde is a chemical compound with the molecular formula C8H6BrFO2. It is a benzaldehyde derivative with a bromine atom at the 3-position, a fluorine atom at the 2-position, and a methoxy group at the 6-position. 3-Bromo-2-fluoro-6-methoxybenzaldehyde is commonly used in organic synthesis and pharmaceutical research as a building block for the synthesis of various biologically active compounds. Its unique structure and functional groups make it a versatile intermediate for the preparation of potentially valuable pharmaceuticals and agrochemicals. Additionally, its properties and reactivity make it a useful tool in understanding and studying chemical reactions and mechanisms.
Check Digit Verification of cas no
The CAS Registry Mumber 1160653-94-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,6,0,6,5 and 3 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1160653-94:
(9*1)+(8*1)+(7*6)+(6*0)+(5*6)+(4*5)+(3*3)+(2*9)+(1*4)=140
140 % 10 = 0
So 1160653-94-0 is a valid CAS Registry Number.
1160653-94-0Relevant articles and documents
METHODS OF TREATING CREATINE TRANSPORTER DEFICIENCY
-
Paragraph 0319-0320, (2021/10/02)
Disclosed are methods of treating creatine transporter deficiency, comprising administering to a mammal in need thereof a therapeutically effective amount of a compound that increases transport of a substrate by a mutant or wild-type creatine transporter. Also disclosed are methods of increasing transport of guanidinoacetic acid or a salt thereof across the blood-brain barrier of a mammal, and methods of decreasing accumulation or the concentration of guanidinoacetic acid or a salt thereof in a mammalian cell.
IMIDAZOPYRIDINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY
-
Page/Page column 105, (2015/06/25)
A series of substituted 3H imidazo[4,5-b]pyridine derivatives of formula (I), being potent modulators of human TNFa activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders.
